Yes. This is a huge problem and why my fellowship and career are focused on collaborating with scientists, clinicians, and patients in South Asia. Our drug trails, pre-clinical data, and even our large multicentered clinical trails all suffer from this very problem - the US has very poor diversity in medical trials.…